Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEADERS: Escitalopram Dose Escalation in MDD
NCT01594866Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Seoul National University Hospital. Started May 2012; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01594866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594866.